New guidance from the Department of Justice (DOJ) issued last September, referred to as the “Yates Memo,” includes an increased focus on individual accountability for corporate wrongdoing in both criminal and civil prosecutions.
The heightened investigative activity by the DOJ will have significant legal consequences for your laboratory or pathology group as well as your CEO, board directors, compliance staff, and other members of your management team.
The DOJ’s focus on criminal sanctions and individual accountability has been evident in its recent activities. It’s clear that your laboratory or pathology group will need a strong compliance program with sufficient resources to address compliance matters and avoid potential legal sanctions and criminal prosecution. Good thing there’s a webinar from Pathology Webinars that can help you create one.
Get the latest on the the DOJ’s enforcement activities and how these will affect your organization when you order the CD “Individual Accountability in Government Healthcare Enforcement: How to Create and Implement an Effective Corporate Regulatory and Compliance Program,” which is scheduled for Wednesday, July 20, 2016. Listen as compliance and fraud experts Charles Dunham from Epstein Becker & Green, PC and Jose Tabuena with UT Southwestern Medical Center provide insight into expanding government investigative actions and give you the strategies you can use to improve your corporate and regulatory compliance efforts.
You’ll get an overview of the current regulatory and enforcement landscape, including what’s happened since the Yates Memo and other DOJ guidance was published last September. Find out how your laboratory should respond to a government investigation under the new guidelines. And come away with several key tactics that your directors can use to carry out compliance and internal investigation functions correctly.
Whether you’re a CEO, chief financial officer, laboratory manager, compliance or privacy officer, board director, or in-house counsel—anyone who needs to protect themselves from the DOJ’s enforcement activities—this webinar is a must-attend.
Charles Dunham is a business and healthcare-law attorney at Epstein Becker & Green, P.C. His national practice includes representation of healthcare providers and health-related entities, with a focus on clinical laboratories and pathology practices. He provides general counsel on corporate and health regulatory compliance, as well as transactional matters, including mergers, acquisitions and business ventures. Mr. Dunham also represents healthcare providers in government enforcement actions and commercial litigation.
Jose Tabuena is an experienced compliance officer, fraud specialist, and attorney specializing in healthcare legal and compliance management. He is an active thought leader, published author, regular columnist with Compliance Week, and teaches as an adjunct faculty instructor for the Widener University Delaware Law School, Masters of Jurisprudence Program.
Mr. Tabuena has held major compliance and internal audit roles at Kaiser Permanente, Texas Health Resources, Orion Health, Concentra | Humana, and UT Southwestern Medical Center. He has experience in a wide range of healthcare services including toxicology laboratories, specialty pharmacies, ambulatory hospitals, and physician management practices. He is an Open Compliance & Ethics Group (OCEG) Fellow, Certified Fraud Examiner (CFE), and Certified in Healthcare Compliance (CHC).